
A sit-down with members of the Deloitte team, who discuss the findings of the company’s yearly research and development report
Nicholas Saraceno is Editor of Pharmaceutical Commerce. He can be reached at [email protected].

A sit-down with members of the Deloitte team, who discuss the findings of the company’s yearly research and development report

Administrator on how pandemic has affected milestone events—the so-called “biodollars”—in life sciences’ deal structures

Software company on mission to infuse efficiency into the pharmacy benefits system

Capital infusion, Nasdaq debut ignite ‘agile’ approach to attracting patients without bounds

A digital health company’s quest to improve the delivery and scaling of lab testing

Healthcare Distribution Alliance CEO talks Covid lessons from onset until now—and how this key pharma link is faring in the current supply chain crisis

One pharma’s IVF education and access mission

Delivering critical insights and relevant messaging at precise moments of the patient journey

Is it the next wave of communication for sales and marketing teams?

The quest to standardize RFID tagging across the pharma supply chain

Market intelligence analyst discusses new trends and emerging strategies in pharma revenue management, given today’s fast-evolving technological and regulatory dynamics

C-suite executive shares knowledge surrounding data security and risk mitigation

Digital healthcare company joins the magazine's first ever podcast episode

More leverage for community-based pharmacies and rules changes for drug-pricing reporting

A one-on-one with Fabian Gerlinghaus, co-founder and CEO of Cellares, who discusses the quest to overcome bottlenecks in industrial scale cell therapy manufacturing